Clinical trials
Recruiting Hypertension trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2019 | 1 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospices Civils de Lyon | 2 |
| University Hospital, Toulouse | 2 |
| Alnylam Pharmaceuticals | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Julius Clinical | 1 |
| Newcastle University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 20 |
| Cardiovascular Diseases | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Obesity | 3 |
| Dyslipidemias | 2 |
| Fatty Liver | 2 |
| Hypertrophy, Left Ventricular | 2 |
| Liver Cirrhosis | 2 |
| Adrenocortical Adenoma | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.